img

Global Synthetic Peptide Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Synthetic Peptide Vaccine Market Research Report 2024

Synthetic peptide vaccines are usually composed of 20–30 amino acids containing the specific epitope of an antigen related to infectious and/or chronic diseases including cancers.
According to Mr Accuracy reports new survey, global Synthetic Peptide Vaccine market is projected to reach US$ 3409.4 million in 2029, increasing from US$ 2578 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Peptide Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Synthetic Peptide Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Segment by Type
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)

Segment by Application


Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Peptide Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Synthetic Peptide Vaccine Market Overview
1.1 Product Overview and Scope of Synthetic Peptide Vaccine
1.2 Synthetic Peptide Vaccine Segment by Type
1.2.1 Global Synthetic Peptide Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Solution Phase Synthesis (SPS)
1.2.3 Solid Phase Peptide Synthesis (SPPS)
1.3 Synthetic Peptide Vaccine Segment by Application
1.3.1 Global Synthetic Peptide Vaccine Market Value by Application: (2024-2034)
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Gastric Cancer
1.3.5 Lung Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Global Synthetic Peptide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Synthetic Peptide Vaccine Revenue 2018-2029
1.4.2 Global Synthetic Peptide Vaccine Sales 2018-2029
1.4.3 Global Synthetic Peptide Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Synthetic Peptide Vaccine Market Competition by Manufacturers
2.1 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Synthetic Peptide Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Synthetic Peptide Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
2.7 Synthetic Peptide Vaccine Market Competitive Situation and Trends
2.7.1 Synthetic Peptide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Synthetic Peptide Vaccine Players Market Share by Revenue
2.7.3 Global Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Synthetic Peptide Vaccine Retrospective Market Scenario by Region
3.1 Global Synthetic Peptide Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Synthetic Peptide Vaccine Global Synthetic Peptide Vaccine Sales by Region: 2018-2029
3.2.1 Global Synthetic Peptide Vaccine Sales by Region: 2018-2024
3.2.2 Global Synthetic Peptide Vaccine Sales by Region: 2024-2029
3.3 Global Synthetic Peptide Vaccine Global Synthetic Peptide Vaccine Revenue by Region: 2018-2029
3.3.1 Global Synthetic Peptide Vaccine Revenue by Region: 2018-2024
3.3.2 Global Synthetic Peptide Vaccine Revenue by Region: 2024-2029
3.4 North America Synthetic Peptide Vaccine Market Facts & Figures by Country
3.4.1 North America Synthetic Peptide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Synthetic Peptide Vaccine Sales by Country (2018-2029)
3.4.3 North America Synthetic Peptide Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Peptide Vaccine Market Facts & Figures by Country
3.5.1 Europe Synthetic Peptide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Synthetic Peptide Vaccine Sales by Country (2018-2029)
3.5.3 Europe Synthetic Peptide Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Peptide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Synthetic Peptide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Synthetic Peptide Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Synthetic Peptide Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Synthetic Peptide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Synthetic Peptide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Synthetic Peptide Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Synthetic Peptide Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Synthetic Peptide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Peptide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Peptide Vaccine Sales by Type (2018-2029)
4.1.1 Global Synthetic Peptide Vaccine Sales by Type (2018-2024)
4.1.2 Global Synthetic Peptide Vaccine Sales by Type (2024-2029)
4.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Synthetic Peptide Vaccine Revenue by Type (2018-2029)
4.2.1 Global Synthetic Peptide Vaccine Revenue by Type (2018-2024)
4.2.2 Global Synthetic Peptide Vaccine Revenue by Type (2024-2029)
4.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Synthetic Peptide Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Synthetic Peptide Vaccine Sales by Application (2018-2029)
5.1.1 Global Synthetic Peptide Vaccine Sales by Application (2018-2024)
5.1.2 Global Synthetic Peptide Vaccine Sales by Application (2024-2029)
5.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Synthetic Peptide Vaccine Revenue by Application (2018-2029)
5.2.1 Global Synthetic Peptide Vaccine Revenue by Application (2018-2024)
5.2.2 Global Synthetic Peptide Vaccine Revenue by Application (2024-2029)
5.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Synthetic Peptide Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Anergis
6.1.1 Anergis Corporation Information
6.1.2 Anergis Description and Business Overview
6.1.3 Anergis Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Anergis Synthetic Peptide Vaccine Product Portfolio
6.1.5 Anergis Recent Developments/Updates
6.2 Antigen Express
6.2.1 Antigen Express Corporation Information
6.2.2 Antigen Express Description and Business Overview
6.2.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Antigen Express Synthetic Peptide Vaccine Product Portfolio
6.2.5 Antigen Express Recent Developments/Updates
6.3 Apitope Technology
6.3.1 Apitope Technology Corporation Information
6.3.2 Apitope Technology Description and Business Overview
6.3.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Apitope Technology Synthetic Peptide Vaccine Product Portfolio
6.3.5 Apitope Technology Recent Developments/Updates
6.4 Artificial Cell Technologies
6.4.1 Artificial Cell Technologies Corporation Information
6.4.2 Artificial Cell Technologies Description and Business Overview
6.4.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio
6.4.5 Artificial Cell Technologies Recent Developments/Updates
6.5 Benovus Bio
6.5.1 Benovus Bio Corporation Information
6.5.2 Benovus Bio Description and Business Overview
6.5.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Benovus Bio Synthetic Peptide Vaccine Product Portfolio
6.5.5 Benovus Bio Recent Developments/Updates
6.6 Celgene Corporation
6.6.1 Celgene Corporation Corporation Information
6.6.2 Celgene Corporation Description and Business Overview
6.6.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Celgene Corporation Synthetic Peptide Vaccine Product Portfolio
6.6.5 Celgene Corporation Recent Developments/Updates
6.7 Immatics biotechnologies
6.6.1 Immatics biotechnologies Corporation Information
6.6.2 Immatics biotechnologies Description and Business Overview
6.6.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio
6.7.5 Immatics biotechnologies Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Merck Synthetic Peptide Vaccine Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 ImmunoCellular Therapeutics
6.9.1 ImmunoCellular Therapeutics Corporation Information
6.9.2 ImmunoCellular Therapeutics Description and Business Overview
6.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio
6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.10 ISA Pharmaceuticals
6.10.1 ISA Pharmaceuticals Corporation Information
6.10.2 ISA Pharmaceuticals Description and Business Overview
6.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio
6.10.5 ISA Pharmaceuticals Recent Developments/Updates
6.11 Lytix Biopharma
6.11.1 Lytix Biopharma Corporation Information
6.11.2 Lytix Biopharma Synthetic Peptide Vaccine Description and Business Overview
6.11.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio
6.11.5 Lytix Biopharma Recent Developments/Updates
6.12 Spotlight Innovation
6.12.1 Spotlight Innovation Corporation Information
6.12.2 Spotlight Innovation Synthetic Peptide Vaccine Description and Business Overview
6.12.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio
6.12.5 Spotlight Innovation Recent Developments/Updates
6.13 OncoTherapy Science
6.13.1 OncoTherapy Science Corporation Information
6.13.2 OncoTherapy Science Synthetic Peptide Vaccine Description and Business Overview
6.13.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio
6.13.5 OncoTherapy Science Recent Developments/Updates
6.14 Peptech
6.14.1 Peptech Corporation Information
6.14.2 Peptech Synthetic Peptide Vaccine Description and Business Overview
6.14.3 Peptech Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Peptech Synthetic Peptide Vaccine Product Portfolio
6.14.5 Peptech Recent Developments/Updates
6.15 Pharmasyntez
6.15.1 Pharmasyntez Corporation Information
6.15.2 Pharmasyntez Synthetic Peptide Vaccine Description and Business Overview
6.15.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Pharmasyntez Synthetic Peptide Vaccine Product Portfolio
6.15.5 Pharmasyntez Recent Developments/Updates
6.16 Sumitomo Dainippon Pharma
6.16.1 Sumitomo Dainippon Pharma Corporation Information
6.16.2 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Description and Business Overview
6.16.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio
6.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.17 TapImmune
6.17.1 TapImmune Corporation Information
6.17.2 TapImmune Synthetic Peptide Vaccine Description and Business Overview
6.17.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 TapImmune Synthetic Peptide Vaccine Product Portfolio
6.17.5 TapImmune Recent Developments/Updates
6.18 Targovax
6.18.1 Targovax Corporation Information
6.18.2 Targovax Synthetic Peptide Vaccine Description and Business Overview
6.18.3 Targovax Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Targovax Synthetic Peptide Vaccine Product Portfolio
6.18.5 Targovax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Peptide Vaccine Industry Chain Analysis
7.2 Synthetic Peptide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Peptide Vaccine Production Mode & Process
7.4 Synthetic Peptide Vaccine Sales and Marketing
7.4.1 Synthetic Peptide Vaccine Sales Channels
7.4.2 Synthetic Peptide Vaccine Distributors
7.5 Synthetic Peptide Vaccine Customers
8 Synthetic Peptide Vaccine Market Dynamics
8.1 Synthetic Peptide Vaccine Industry Trends
8.2 Synthetic Peptide Vaccine Market Drivers
8.3 Synthetic Peptide Vaccine Market Challenges
8.4 Synthetic Peptide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Synthetic Peptide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Synthetic Peptide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Synthetic Peptide Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Synthetic Peptide Vaccine Sales (K Dose) of Key Manufacturers (2018-2024)
Table 5. Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Synthetic Peptide Vaccine Average Price (US$/Dose) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Synthetic Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Peptide Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Synthetic Peptide Vaccine Sales by Region (2018-2024) & (K Dose)
Table 18. Global Synthetic Peptide Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Synthetic Peptide Vaccine Sales by Region (2024-2029) & (K Dose)
Table 20. Global Synthetic Peptide Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Synthetic Peptide Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Synthetic Peptide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Synthetic Peptide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Synthetic Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 27. North America Synthetic Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 28. North America Synthetic Peptide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Synthetic Peptide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Synthetic Peptide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Synthetic Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 32. Europe Synthetic Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Synthetic Peptide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Synthetic Peptide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Synthetic Peptide Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Synthetic Peptide Vaccine Sales by Region (2018-2024) & (K Dose)
Table 37. Asia Pacific Synthetic Peptide Vaccine Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Synthetic Peptide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Synthetic Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 42. Latin America Synthetic Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Synthetic Peptide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Synthetic Peptide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Synthetic Peptide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Synthetic Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 47. Middle East & Africa Synthetic Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Synthetic Peptide Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Synthetic Peptide Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Synthetic Peptide Vaccine Sales (K Dose) by Type (2018-2024)
Table 51. Global Synthetic Peptide Vaccine Sales (K Dose) by Type (2024-2029)
Table 52. Global Synthetic Peptide Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Synthetic Peptide Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2018-2024)
Table 59. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2024-2029)
Table 60. Global Synthetic Peptide Vaccine Sales (K Dose) by Application (2018-2024)
Table 61. Global Synthetic Peptide Vaccine Sales (K Dose) by Application (2024-2029)
Table 62. Global Synthetic Peptide Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Synthetic Peptide Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2018-2024)
Table 69. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2024-2029)
Table 70. Anergis Corporation Information
Table 71. Anergis Description and Business Overview
Table 72. Anergis Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 73. Anergis Synthetic Peptide Vaccine Product
Table 74. Anergis Recent Developments/Updates
Table 75. Antigen Express Corporation Information
Table 76. Antigen Express Description and Business Overview
Table 77. Antigen Express Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 78. Antigen Express Synthetic Peptide Vaccine Product
Table 79. Antigen Express Recent Developments/Updates
Table 80. Apitope Technology Corporation Information
Table 81. Apitope Technology Description and Business Overview
Table 82. Apitope Technology Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 83. Apitope Technology Synthetic Peptide Vaccine Product
Table 84. Apitope Technology Recent Developments/Updates
Table 85. Artificial Cell Technologies Corporation Information
Table 86. Artificial Cell Technologies Description and Business Overview
Table 87. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 88. Artificial Cell Technologies Synthetic Peptide Vaccine Product
Table 89. Artificial Cell Technologies Recent Developments/Updates
Table 90. Benovus Bio Corporation Information
Table 91. Benovus Bio Description and Business Overview
Table 92. Benovus Bio Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 93. Benovus Bio Synthetic Peptide Vaccine Product
Table 94. Benovus Bio Recent Developments/Updates
Table 95. Celgene Corporation Corporation Information
Table 96. Celgene Corporation Description and Business Overview
Table 97. Celgene Corporation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 98. Celgene Corporation Synthetic Peptide Vaccine Product
Table 99. Celgene Corporation Recent Developments/Updates
Table 100. Immatics biotechnologies Corporation Information
Table 101. Immatics biotechnologies Description and Business Overview
Table 102. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 103. Immatics biotechnologies Synthetic Peptide Vaccine Product
Table 104. Immatics biotechnologies Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 108. Merck Synthetic Peptide Vaccine Product
Table 109. Merck Recent Developments/Updates
Table 110. ImmunoCellular Therapeutics Corporation Information
Table 111. ImmunoCellular Therapeutics Description and Business Overview
Table 112. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 113. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product
Table 114. ImmunoCellular Therapeutics Recent Developments/Updates
Table 115. ISA Pharmaceuticals Corporation Information
Table 116. ISA Pharmaceuticals Description and Business Overview
Table 117. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 118. ISA Pharmaceuticals Synthetic Peptide Vaccine Product
Table 119. ISA Pharmaceuticals Recent Developments/Updates
Table 120. Lytix Biopharma Corporation Information
Table 121. Lytix Biopharma Description and Business Overview
Table 122. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 123. Lytix Biopharma Synthetic Peptide Vaccine Product
Table 124. Lytix Biopharma Recent Developments/Updates
Table 125. Spotlight Innovation Corporation Information
Table 126. Spotlight Innovation Description and Business Overview
Table 127. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 128. Spotlight Innovation Synthetic Peptide Vaccine Product
Table 129. Spotlight Innovation Recent Developments/Updates
Table 130. OncoTherapy Science Corporation Information
Table 131. OncoTherapy Science Description and Business Overview
Table 132. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 133. OncoTherapy Science Synthetic Peptide Vaccine Product
Table 134. OncoTherapy Science Recent Developments/Updates
Table 135. Peptech Corporation Information
Table 136. Peptech Description and Business Overview
Table 137. Peptech Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 138. Peptech Synthetic Peptide Vaccine Product
Table 139. Peptech Recent Developments/Updates
Table 140. Pharmasyntez Corporation Information
Table 141. Pharmasyntez Description and Business Overview
Table 142. Pharmasyntez Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 143. Pharmasyntez Synthetic Peptide Vaccine Product
Table 144. Pharmasyntez Recent Developments/Updates
Table 145. Sumitomo Dainippon Pharma Corporation Information
Table 146. Sumitomo Dainippon Pharma Description and Business Overview
Table 147. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 148. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product
Table 149. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 150. TapImmune Corporation Information
Table 151. TapImmune Description and Business Overview
Table 152. TapImmune Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 153. TapImmune Synthetic Peptide Vaccine Product
Table 154. TapImmune Recent Developments/Updates
Table 155. Targovax Corporation Information
Table 156. Targovax Description and Business Overview
Table 157. Targovax Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 158. Targovax Synthetic Peptide Vaccine Product
Table 159. Targovax Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Synthetic Peptide Vaccine Distributors List
Table 163. Synthetic Peptide Vaccine Customers List
Table 164. Synthetic Peptide Vaccine Market Trends
Table 165. Synthetic Peptide Vaccine Market Drivers
Table 166. Synthetic Peptide Vaccine Market Challenges
Table 167. Synthetic Peptide Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Synthetic Peptide Vaccine
Figure 2. Global Synthetic Peptide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Synthetic Peptide Vaccine Market Share by Type in 2022 & 2029
Figure 4. Solution Phase Synthesis (SPS) Product Picture
Figure 5. Solid Phase Peptide Synthesis (SPPS) Product Picture
Figure 6. Global Synthetic Peptide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Synthetic Peptide Vaccine Market Share by Application in 2022 & 2029
Figure 8. Prostate Cancer
Figure 9. Breast Cancer
Figure 10. Gastric Cancer
Figure 11. Lung Cancer
Figure 12. Pancreatic Cancer
Figure 13. Others
Figure 14. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Synthetic Peptide Vaccine Market Size (2018-2029) & (US$ Million)
Figure 16. Global Synthetic Peptide Vaccine Sales (2018-2029) & (K Dose)
Figure 17. Global Synthetic Peptide Vaccine Average Price (US$/Dose) & (2018-2029)
Figure 18. Synthetic Peptide Vaccine Report Years Considered
Figure 19. Synthetic Peptide Vaccine Sales Share by Manufacturers in 2022
Figure 20. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Synthetic Peptide Vaccine Players: Market Share by Revenue in 2022
Figure 22. Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Synthetic Peptide Vaccine Sales Market Share by Country (2018-2029)
Figure 25. North America Synthetic Peptide Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. United States Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Synthetic Peptide Vaccine Sales Market Share by Country (2018-2029)
Figure 29. Europe Synthetic Peptide Vaccine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Synthetic Peptide Vaccine Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Synthetic Peptide Vaccine Revenue Market Share by Region (2018-2029)
Figure 37. China Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Synthetic Peptide Vaccine Sales Market Share by Country (2018-2029)
Figure 47. Latin America Synthetic Peptide Vaccine Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Synthetic Peptide Vaccine Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Synthetic Peptide Vaccine Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Synthetic Peptide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Synthetic Peptide Vaccine by Type (2018-2029)
Figure 57. Global Revenue Market Share of Synthetic Peptide Vaccine by Type (2018-2029)
Figure 58. Global Synthetic Peptide Vaccine Price (US$/Dose) by Type (2018-2029)
Figure 59. Global Sales Market Share of Synthetic Peptide Vaccine by Application (2018-2029)
Figure 60. Global Revenue Market Share of Synthetic Peptide Vaccine by Application (2018-2029)
Figure 61. Global Synthetic Peptide Vaccine Price (US$/Dose) by Application (2018-2029)
Figure 62. Synthetic Peptide Vaccine Value Chain
Figure 63. Synthetic Peptide Vaccine Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries